Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal of Hematology and Oncology | journal | 6.046 Q1 | 144 | 169 | 497 | 18270 | 11261 | 433 | 20.94 | 108.11 | 41.80 | |
2 | Signal Transduction and Targeted Therapy | journal | 6.630 Q1 | 117 | 389 | 778 | 39771 | 14754 | 479 | 19.08 | 102.24 | 42.94 | |
3 | Molecular Cancer | journal | 8.703 Q1 | 196 | 208 | 475 | 17628 | 16683 | 427 | 28.64 | 84.75 | 40.29 | |
4 | Nature Reviews Cancer | journal | 20.977 Q1 | 505 | 111 | 325 | 8402 | 10652 | 174 | 37.68 | 75.69 | 34.76 | |
5 | NAR Cancer | journal | 17 | 44 | 90 | 3329 | 432 | 89 | 4.85 | 75.66 | 42.22 | ||
6 | Experimental Hematology and Oncology | journal | 1.908 Q1 | 42 | 106 | 126 | 7331 | 969 | 107 | 8.64 | 69.16 | 42.75 | |
7 | Cancer Cell International | journal | 1.145 Q2 | 80 | 408 | 1569 | 28061 | 8859 | 1567 | 5.52 | 68.78 | 43.15 | |
8 | Journal of Experimental and Clinical Cancer Research | journal | 2.413 Q1 | 120 | 330 | 1058 | 21141 | 11401 | 1056 | 9.37 | 64.06 | 44.91 | |
9 | Molecular Therapy - Oncolytics | journal | 1.339 Q2 | 42 | 154 | 420 | 9805 | 2379 | 420 | 5.60 | 63.67 | 40.14 | |
10 | Advances in Biological Regulation | journal | 1.276 Q2 | 69 | 30 | 123 | 1710 | 535 | 117 | 4.00 | 57.00 | 42.74 | |
11 | Cancer Communications | journal | 2.677 Q1 | 79 | 110 | 260 | 6255 | 2656 | 186 | 9.87 | 56.86 | 42.69 | |
12 | Epigenomics | journal | 0.809 Q3 | 77 | 125 | 429 | 6934 | 1467 | 401 | 3.09 | 55.47 | 45.35 | |
13 | npj Precision Oncology | journal | 2.520 Q1 | 36 | 94 | 166 | 5100 | 1347 | 163 | 7.52 | 54.26 | 37.23 | |
14 | FASEB BioAdvances | journal | 0.731 Q3 | 18 | 59 | 209 | 3156 | 593 | 201 | 2.86 | 53.49 | 42.07 | |
15 | Endocrine-Related Cancer | journal | 1.255 Q2 | 146 | 74 | 310 | 3956 | 1487 | 302 | 3.83 | 53.46 | 46.89 | |
16 | Cell Death and Disease | journal | 2.188 Q1 | 164 | 1028 | 3018 | 54585 | 27098 | 2982 | 8.33 | 53.10 | 43.98 | |
17 | Infectious Agents and Cancer | journal | 0.583 Q3 | 47 | 61 | 186 | 3193 | 683 | 182 | 3.58 | 52.34 | 44.08 | |
18 | Oncogene | journal | 2.311 Q1 | 370 | 434 | 1506 | 22573 | 11585 | 1497 | 7.33 | 52.01 | 42.32 | |
19 | British Journal of Cancer | journal | 2.867 Q1 | 272 | 427 | 1193 | 21351 | 9632 | 1036 | 7.71 | 50.00 | 41.74 | |
20 | Cell Death Discovery | journal | 1.545 Q1 | 58 | 484 | 594 | 23950 | 3845 | 576 | 6.53 | 49.48 | 43.01 | |
21 | Cancer Gene Therapy | journal | 1.384 Q2 | 99 | 178 | 231 | 8770 | 1418 | 222 | 6.38 | 49.27 | 40.49 | |
22 | Breast Cancer Research | journal | 2.408 Q1 | 175 | 100 | 394 | 4834 | 3039 | 388 | 7.01 | 48.34 | 54.07 | |
23 | Carcinogenesis | journal | 1.071 Q2 | 223 | 116 | 489 | 5290 | 2001 | 473 | 4.46 | 45.60 | 42.05 | |
24 | Cancer Treatment and Research Communications | journal | 0.674 Q3 | 23 | 152 | 357 | 6582 | 933 | 338 | 2.57 | 43.30 | 44.63 | |
25 | Journal for ImmunoTherapy of Cancer | journal | 3.403 Q1 | 117 | 531 | 1395 | 22237 | 14506 | 1384 | 9.00 | 41.88 | 42.18 | |
26 | International Journal of Hyperthermia | journal | 0.762 Q3 | 98 | 160 | 561 | 6613 | 1969 | 541 | 3.07 | 41.33 | 37.38 | |
27 | Cancer Medicine | journal | 1.188 Q2 | 84 | 442 | 2390 | 18227 | 10563 | 2384 | 3.90 | 41.24 | 41.25 | |
28 | ecancermedicalscience | journal | 0.665 Q3 | 47 | 159 | 473 | 6498 | 1111 | 470 | 1.93 | 40.87 | 43.84 | |
29 | BMC Cancer | journal | 1.137 Q2 | 160 | 1343 | 3770 | 54250 | 16278 | 3769 | 3.75 | 40.39 | 41.21 | |
30 | Future Oncology | journal | 0.874 Q2 | 90 | 404 | 1149 | 16286 | 3380 | 1078 | 2.88 | 40.31 | 40.62 | |
31 | Leukemia | journal | 3.376 Q1 | 219 | 339 | 1097 | 13265 | 8491 | 895 | 7.64 | 39.13 | 43.48 | |
32 | Function | journal | 16 | 71 | 102 | 2575 | 283 | 83 | 2.77 | 36.27 | 35.81 | ||
33 | Journal of the National Cancer Institute | journal | 5.409 Q1 | 387 | 262 | 654 | 9150 | 5072 | 461 | 7.02 | 34.92 | 48.38 | |
34 | Leukemia Research | journal | 0.673 Q3 | 96 | 122 | 430 | 4247 | 774 | 293 | 1.76 | 34.81 | 45.67 | |
35 | Neuro-Oncology | journal | 4.833 Q1 | 163 | 260 | 714 | 8931 | 7060 | 450 | 9.68 | 34.35 | 40.76 | |
36 | ESMO Open | journal | 2.196 Q1 | 60 | 252 | 582 | 8577 | 3350 | 502 | 5.80 | 34.04 | 40.25 | |
37 | Hematological Oncology | journal | 1.051 Q2 | 54 | 124 | 339 | 4189 | 963 | 265 | 2.22 | 33.78 | 44.70 | |
38 | Cancer Reports | journal | 0.513 Q4 | 18 | 241 | 245 | 8110 | 509 | 239 | 2.06 | 33.65 | 39.62 | |
39 | Molecular and Clinical Oncology | journal | 0.393 Q4 | 19 | 156 | 605 | 5238 | 915 | 604 | 1.29 | 33.58 | 26.80 | |
40 | Journal of Oral Pathology and Medicine | journal | 0.682 Q3 | 95 | 109 | 400 | 3478 | 1535 | 382 | 3.35 | 31.91 | 39.34 | |
41 | Prostate Cancer and Prostatic Diseases | journal | 1.676 Q1 | 78 | 122 | 313 | 3807 | 1509 | 281 | 4.73 | 31.20 | 33.76 | |
42 | Leukemia and Lymphoma | journal | 0.837 Q3 | 102 | 475 | 1552 | 13932 | 2581 | 938 | 1.65 | 29.33 | 43.14 | |
43 | Japanese Journal of Clinical Oncology | journal | 0.743 Q3 | 95 | 202 | 669 | 5293 | 1628 | 595 | 2.05 | 26.20 | 18.90 | |
44 | Molecular and Cellular Oncology | journal | 0.436 Q4 | 37 | 17 | 312 | 392 | 347 | 220 | 1.05 | 23.06 | 54.55 | |
45 | Oral Oncology | journal | 1.271 Q2 | 137 | 467 | 1194 | 10387 | 4006 | 748 | 2.96 | 22.24 | 35.90 | |
46 | European Journal of Cancer | journal | 2.898 Q1 | 245 | 806 | 1353 | 15906 | 9370 | 1084 | 6.24 | 19.73 | 42.57 | |
47 | European Journal of Cancer, Supplement | journal | 0.571 Q3 | 29 | 0 | 14 | 0 | 29 | 13 | 2.07 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®